États-Unis · Plateformes & données · The Motley Fool

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Publié par The Motley Fool · États-Unis il y a 1 h

Résumé détaillé

PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Résumé détaillé

À lire aussi

How much in Roth conversions can you do in 2027 with the new tax brackets?

Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

Heavy rain floods tents housing Gaza displaced people, aid shortages hamper response

Best Stocks Under $5

Fed rate call leaves stock investors watching December closely

Banca Sistema Completes Banca CF+ Merger and Capital Increase

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Résumé détaillé

Partager

À lire aussi

How much in Roth conversions can you do in 2027 with the new tax brackets?

Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

Heavy rain floods tents housing Gaza displaced people, aid shortages hamper response

Best Stocks Under $5

Fed rate call leaves stock investors watching December closely

Banca Sistema Completes Banca CF+ Merger and Capital Increase